Skip Navigation

Journal of Antimicrobial Chemotherapy 2005 56(Supplement 1):i5-i11; doi:10.1093/jac/dki218
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Richardson, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardson, M. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Supplement

Changing patterns and trends in systemic fungal infections

Malcolm D. Richardson1,2,*

1 Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland; 2 Laboratory Diagnostics, Helsinki University Central Hospital, Helsinki, Finland


* Tel: +358-9-191-26894; Fax: +358-9-191-26382; E-mail: Malcolm.Richardson{at}helsinki.fi

Invasive mycoses are a significant and growing public health problem. Although bloodstream infections with Candida albicans may be decreasing in frequency, the number of persons at risk for them continues to grow. Moreover, infections with other Candida species, such as Candida glabrata, are increasing in incidence. Invasive mould infections in general, and Aspergillus infections in particular, are becoming more frequent. Fungal opportunistic infections in persons with AIDS are no longer a major problem in developed countries, but are resulting in significant morbidity and mortality in developing countries with AIDS epidemics. Further studies are needed to define populations at very high risk for fungal opportunistic infections who might benefit from targeted antifungal chemoprophylaxis, which remains the most promising of the potential prevention strategies. This review highlights the changing patterns in risk factors, changes in epidemiology, the impact of changes in medical practice in intensive care and organ transplantation on the incidence of systemic fungal infections, and gives an overview of fungal infections in paediatric patients, patients with haematological malignancy, and the emergence of antifungal resistance.

Keywords: aspergillosis , candidosis , antifungals


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
C. J. Seneviratne, L. J. Jin, Y. H. Samaranayake, and L. P. Samaranayake
Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3259 - 3266.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Burgos, T. E. Zaoutis, C. C. Dvorak, J. A. Hoffman, K. M. Knapp, J. J. Nania, P. Prasad, and W. J. Steinbach
Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases
Pediatrics, May 1, 2008; 121(5): e1286 - e1294.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. A. S. H. Mennink-Kersten, D. Ruegebrink, R. R. Klont, A. Warris, N. M. A. Blijlevens, J. P. Donnelly, and P. E. Verweij
Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure
J. Clin. Microbiol., April 1, 2008; 46(4): 1391 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
E. J. Chung, H. K. Lim, J.-C. Kim, G. J. Choi, E. J. Park, M. H. Lee, Y. R. Chung, and S.-W. Lee
Forest Soil Metagenome Gene Cluster Involved in Antifungal Activity Expression in Escherichia coli
Appl. Envir. Microbiol., February 1, 2008; 74(3): 723 - 730.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
Generalized Papules in a Patient With Acute Myeloid Leukemia Diagnosis
Arch Dermatol, December 1, 2007; 143(12): 1583 - 1588.
[Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Gulshan and W. S. Moye-Rowley
Multidrug Resistance in Fungi
Eukaryot. Cell, November 1, 2007; 6(11): 1933 - 1942.
[Full Text] [PDF]


Home page
Eukaryot CellHome page
C. Gregori, C. Schuller, A. Roetzer, T. Schwarzmuller, G. Ammerer, and K. Kuchler
The High-Osmolarity Glycerol Response Pathway in the Human Fungal Pathogen Candida glabrata Strain ATCC 2001 Lacks a Signaling Branch That Operates in Baker's Yeast
Eukaryot. Cell, September 1, 2007; 6(9): 1635 - 1645.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. Ueno, J. Uno, H. Nakayama, K. Sasamoto, Y. Mikami, and H. Chibana
Development of a Highly Efficient Gene Targeting System Induced by Transient Repression of YKU80 Expression in Candida glabrata
Eukaryot. Cell, July 1, 2007; 6(7): 1239 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
V. Yadav, R. Mandhan, Q. Pasha, S. Pasha, A. Katyal, A. K. Chhillar, J. Gupta, R. Dabur, and G. L. Sharma
An antifungal protein from Escherichia coli
J. Med. Microbiol., May 1, 2007; 56(5): 637 - 644.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
B. Sendid, N. Francois, A. Standaert, E. Dehecq, F. Zerimech, D. Camus, and D. Poulain
Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species
J. Med. Microbiol., April 1, 2007; 56(4): 495 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Soloviev, W. A. Fonzi, R. Sentandreu, E. Pluskota, C. B. Forsyth, S. Yadav, and E. F. Plow
Identification of pH-Regulated Antigen 1 Released from Candida albicans as the Major Ligand for Leukocyte Integrin {alpha}Mbeta2
J. Immunol., February 15, 2007; 178(4): 2038 - 2046.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. B. Arnaud, M. C. Costanzo, M. S. Skrzypek, P. Shah, G. Binkley, C. Lane, S. R. Miyasato, and G. Sherlock
Sequence resources at the Candida Genome Database
Nucleic Acids Res., January 12, 2007; 35(suppl_1): D452 - D456.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
N. Isham and M. A. Ghannoum
Determination of MICs of Aminocandin for Candida spp. and Filamentous Fungi
J. Clin. Microbiol., December 1, 2006; 44(12): 4342 - 4344.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
V. Brown, J. A. Sexton, and M. Johnston
A Glucose Sensor in Candida albicans.
Eukaryot. Cell, October 1, 2006; 5(10): 1726 - 1737.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. Lincopan and A. M. Carmona-Ribeiro
Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole
J. Antimicrob. Chemother., July 1, 2006; 58(1): 66 - 75.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.